Related Experiment Video

Updated: Jun 23, 2026

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis

M S Caplan1

  • 1Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. mcaplan@northshore.org

Journal of Perinatology : Official Journal of the California Perinatal Association
|April 29, 2009
PubMed

Insights

Necrotizing enterocolitis (NEC) in premature infants may be linked to inflammation. Probiotics show promise in reducing NEC risk, but regulated products are needed for this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Gastroenterology
  • Microbiology

Background:

  • Necrotizing enterocolitis (NEC) is a devastating intestinal disease in premature infants.
  • Its exact pathophysiology remains unclear, but inflammatory signaling plays a key role.
  • Current preventive and therapeutic strategies for NEC lack consistent efficacy.

Purpose of the Study:

  • To review the current understanding of probiotics in relation to NEC.
  • To evaluate the potential of probiotic supplementation for NEC prevention and treatment.
  • To highlight the need for caution with available probiotic products.

Main Methods:

  • Literature review of recent studies on NEC pathophysiology and probiotic interventions.
  • Analysis of evidence supporting the role of gut microbiota and probiotics in preterm neonates.
  • Synthesis of current data on the efficacy and safety of probiotics for NEC.

Main Results:

  • Emerging evidence suggests abnormal probiotic colonization in preterm infants.
  • Enteral probiotic supplementation may reduce the incidence of NEC.
  • The specific mechanisms and optimal probiotic strains for NEC require further investigation.

Conclusions:

  • Probiotics represent a promising avenue for NEC prevention and management.
  • Further research is needed to identify effective and safe probiotic formulations.
  • Regulatory oversight is crucial before widespread clinical adoption in high-risk neonates.

More Related Videos

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...